SCHEMBL31397268

SCHEMBL31397268

Cn1c(=O)n(-c2ccc(OCc3ccccc3)nc2OCc2ccccc2)c2ccc(Oc3ccc(CC(=O)O)cc3)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRD5A2 P31213 2/20 0.39
▸ TRIM24 O15164 3/20 0.38
▸ MCL1 Q07820 1/20 0.37
▸ BAK1 Q16611 1/20 0.37
▸ PPARG P37231 2/20 0.36
▸ GRM5 P41594 1/20 0.36
▸ ACACB O00763 1/20 0.36
▸ ACACA Q13085 1/20 0.36
▸ FFAR1 O14842 2/20 0.36
▸ FFAR4 Q5NUL3 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ NR3C1 P04150 1/20 0.35
▸ ROCK2 O75116 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ GALR3 O60755 1/20 0.35
▸ GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24821104 0.93 TRIM24 (0.38) SRD5A2TRIM24MCL1BAK1PPARG
SCHEMBL31397254 0.90 MCL1 (0.38) SRD5A2TRIM24MCL1BAK1PPARG
SCHEMBL24818101 0.90 GRM5 (0.37) SRD5A2TRIM24MCL1BAK1PPARG
SCHEMBL24821102 0.88 SRD5A2 (0.41) SRD5A2TRIM24MCL1BAK1GRM5
SCHEMBL31397430 0.85 FFAR1 (0.41) SRD5A2PPARGGRM5FFAR1PKM
SCHEMBL31397043 0.83 TRIM24 (0.37) SRD5A2TRIM24MCL1BAK1PPARG
SCHEMBL30274180 0.83 PKM (0.41) SRD5A2TRIM24MCL1BAK1GRM5
SCHEMBL31397093 0.83 MCHR1 (0.36) SRD5A2GRM5FFAR1PKM
SCHEMBL30273755 0.83 HDAC6 (0.40) SRD5A2TRIM24MCL1BAK1GRM5
SCHEMBL23540929 0.83 DGAT1 (0.40) PPARGGRM5FFAR4PKMPTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240424111-A1 Degrader Compounds and Uses Thereof CALICO LIFE SCIENCES LLC (US) 2024-12-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240424111-A1 Degrader Compounds and Uses Thereof PTPN1, PTPN2, PTPN5 SRD5A2 2076/4885TRIM24 2371/4885MCL1 1571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback